Trial site
Keimyung University - Dongsan Medical Center
- 44running trials
- 28closed trials
The trials here
What the 72 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease33 trials
- Heart failure6 trials
- Atrial fibrillation5 trials
- Lung cancer4 trials
- High blood pressure3 trials
- Stroke3 trials
- Type 2 diabetes3 trials
- Chronic kidney disease2 trials
- Endometrial cancer2 trials
- Familial hypercholesterolaemia2 trials
- IgA nephropathy2 trials
- Antiphospholipid syndrome1 trial
- and 22 more
- Phase
- Phase 315 trials
- Phase 410 trials
- Phase 1/23 trials
- Phase 22 trials
- Phase 2/32 trials
- Status
- Completed26 trials
- Recruiting24 trials
- Active, not recruiting17 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Seung-Jung Park9 trials
- Duk-Woo Park, MD7 trials
- Samsung Medical Center6 trials
- Seoul National University Hospital5 trials
- Abbott Medical Devices3 trials
- and 36 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Shared Decision Making for Choosing Autosomal DOminant Polycystic Kidney Disease Treatment
Recruiting
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
Active, not recruiting
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Enrolling by invitation
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
Recruiting
Active, not recruiting
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
Active, not recruiting
Recruiting
KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis
Active, not recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
Active, not recruiting
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy
Active, not recruiting
Active, not recruiting
Active, not recruiting
Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Study of the Natural History of FFR Guided Percutaneous Coronary Intervention
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease19 recruiting
- Heart failure3 recruiting
- Aortic stenosis1 recruiting
- Chronic kidney disease1 recruiting
- High blood pressure1 recruiting
- IgA nephropathy1 recruiting
- Lupus (SLE)1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Nephrotic syndrome1 recruiting
- Peripheral artery disease1 recruiting
- Polycystic kidney disease1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder
Completed
Completed
Completed
Completed
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
Completed
Completed
Completed
Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea
Completed
Completed
Completed
Completed
Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Completed
Resolution of Thrombi in Left Atrial Appendage With Edoxaban
Completed
Completed
Completed
TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI
Completed
Completed
Completed
Completed
Completed
Completed
Multicenter Registry for Angiography-Derived Quantitative Flow Ratio
Terminated
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Recruiting
Prospective Evaluation of MyocaRdial PerFUSion ComputEd Tomography Trial
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026